Viewing Study NCT01629966


Ignite Creation Date: 2025-12-24 @ 4:27 PM
Ignite Modification Date: 2025-12-27 @ 6:10 AM
Study NCT ID: NCT01629966
Status: COMPLETED
Last Update Posted: 2019-12-18
First Post: 2012-06-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder
Sponsor: Forest Laboratories
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2012-06-30
Start Date Type: ACTUAL
Primary Completion Date: 2014-02-28
Primary Completion Date Type: ACTUAL
Completion Date: 2014-03-31
Completion Date Type: ACTUAL
First Submit Date: 2012-06-26
First Submit QC Date: None
Study First Post Date: 2012-06-28
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2019-12-04
Results First Submit QC Date: None
Results First Post Date: 2019-12-18
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2015-03-18
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2019-12-04
Last Update Post Date: 2019-12-18
Last Update Post Date Type: ACTUAL